| Cancer | ID | Symbol | Immune Pathway | P value | FDR value | ES value | Score | number |
|---|---|---|---|---|---|---|---|---|
| ACC | ENSG00000223534 | HLA-DQB1-AS1 | Antigen Processing and Presentation | 1.183e-03 | 3.772e-03 | 0.6635 | 0.9976 | 28 |
| ACC | ENSG00000223534 | HLA-DQB1-AS1 | Antimicrobials | 1.035e-03 | 3.772e-03 | 0.4497 | 0.9979 | 110 |
| ACC | ENSG00000223534 | HLA-DQB1-AS1 | Chemokine Receptors | 1.414e-03 | 3.772e-03 | 0.7052 | 0.9972 | 14 |
| ACC | ENSG00000223534 | HLA-DQB1-AS1 | Cytokine Receptors | 1.072e-03 | 3.772e-03 | 0.434 | 0.9979 | 55 |
| ACC | ENSG00000223534 | HLA-DQB1-AS1 | Natural Killer Cell Cytotoxicity | 1.192e-03 | 3.772e-03 | 0.5353 | 0.9976 | 40 |
| ACC | ENSG00000223534 | HLA-DQB1-AS1 | TCR signaling Pathway | 1.222e-03 | 3.772e-03 | 0.5578 | 0.9976 | 33 |
| ACC | ENSG00000223537 | AL109947.1 | Cytokines | 1.456e-03 | 2.329e-02 | 0.3867 | 0.9971 | 56 |
| ACC | ENSG00000223546 | LINC00630 | Antigen Processing and Presentation | 2.132e-03 | 1.706e-02 | -0.5155 | -0.9957 | 20 |
| ACC | ENSG00000223546 | LINC00630 | TCR signaling Pathway | 1.876e-03 | 1.706e-02 | 0.4815 | 0.9962 | 27 |
| ACC | ENSG00000223552 | CCR5AS | Antigen Processing and Presentation | 1.267e-03 | 8.412e-03 | 0.5791 | 0.9975 | 40 |
| ACC | ENSG00000223552 | CCR5AS | Antimicrobials | 1.092e-03 | 8.412e-03 | 0.4579 | 0.9978 | 104 |
| ACC | ENSG00000223552 | CCR5AS | Interleukins | 1.577e-03 | 8.412e-03 | 0.732 | 0.9968 | 7 |
| ACC | ENSG00000223576 | AL355001.1 | TGFb Family Member | 1.536e-03 | 2.339e-02 | 0.6459 | 0.9969 | 7 |